Polymorphisms in telomere maintenance genes and risk of lung cancer Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009
Airway gene expression as a link between COPD and lung cancer Source: Annual Congress 2009 - The lung cancer-COPD nexus Year: 2009
Telomere length, COPD and emphysema as risk factors for lung cancer Source: Eur Respir J 2017; 49(1): 1601521; DOI: 10.1183/13993003.01521-2016 Year: 2017
DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013
Epithelial cell matrix proteins and lymphocyte activation genes in COPD and lung cancer Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
Cellular matrix and proliferation proteins in COPD and lung cancer Source: Annual Congress 2008 - Airway infection and host defence Year: 2008
Is mitochondrial dysfunction a driving mechanism linking COPD to nonsmall cell lung carcinoma? Source: Eur Respir Rev, 26 (146) 170040; 10.1183/16000617.0040-2017 Year: 2017
Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017
MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD Source: Eur Respir J 2014; 43: 1740-1749 Year: 2014
Expression of PD1, COPD and lung cancer. Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016
Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015
Choice of endogenous control for gene expression in nonsmall cell lung cancer Source: Eur Respir J 2005; 26: 1002-1008 Year: 2005
Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007
Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009
Telomere length in circulating leukocytes is associated with lung function and disease Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
Gene expression profiling in non-small cell lung cancer (NSCLC) according to smoking status Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008
Multi-omic molecular profiling of lung cancer in COPD Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017 Year: 2018
LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017
Fibroblasts from IPF explanted lungs have mitochondrial dysfunction and short telomeres leading to an increased senescence phenotype Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016